2027 General Election:
-- d-- h-- m-- sSee Politics Coverage →
In Other News · United States · Business
A little-known biotech’s high-stakes cancer bet just paid off and its shares doubled
Source: CNBC
Summary
Genmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.
Continue reading on CNBC →
You'll be taken to www.cnbc.com
← Back to In Other News
↑
Customize
Reject All
Accept All
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
None